ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19

Figure 1

The level of ACE2 in KIRC. (a) Upregulation or downregulation of ACE2 in different types of cancers, including KIRC, compared to the different types of normal tissues. (Oncomine). ((b), (c)) Plot showing ACE2 mRNA expression in KIRC and normal tissues in the dataset from Oncomine. (d) Plot showing ACE2 protein expression in KIRC and normal tissues in the dataset from UALCAN. (e) Immunohistochemical staining showing the protein level of ACE2 in KIRC and normal tissue (the Human Protein Atlas).

(a)

(b)

(c)

(d)

(e)